Skip to the answer

Ropivacaine Uses, Dosage, Side Effects and Interactions

Brand name
Naropin

Naropin was the first ropivacaine product the FDA approved, in September 1996. An FDA-approved generic with the same active ingredient is listed.

Ropivacaine is an injected numbing medicine (an amide local anesthetic) used by clinicians for anesthesia during surgery and for acute pain control, such as after surgery or during labor.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About RopivacaineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Ropivacaine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Ropivacaine (Naropin) is a numbing medicine, an amide local anesthetic, that a trained clinician injects near nerves, around a surgical site or into the epidural space to block pain signals for surgery, labor or recovery; on the U.S. market since about 1996, it is a common choice for epidurals and nerve blocks, and FDA-approved generics are listed. Most people tolerate it well; the side effects seen most are a dip in blood pressure, nausea and itching. The danger is too much reaching the blood, which can affect the nerves and heart, so speak up at once about ringing ears, tingling around the mouth or a metallic taste.

Key Takeaways From the HelloPharmacist Team

  • Expect a clinician to inject it or run it as a continuous epidural infusion, with your blood pressure and heart watched.
  • Before it is given, mention liver, kidney or heart problems and any past reaction to numbing medicines, since these can change the plan.
  • Share your full medicine list; fluvoxamine can raise its blood levels and amiodarone can add to its effects on the heart.
  • After an epidural, report leg weakness, numbness or loss of bladder or bowel control that lingers once the numbing should have worn off.

How we write and review this content: our editorial policy

Ropivacaine by the Numbers

Strengths
4
in one form
Makers and packagers
19
Earliest FDA record
1996
Rank by Medicaid prescriptions
#730 of 1,682 drugs
More prescriptions than 56% of the 1,682 drugs we measure
32,308 prescriptions, Q1–Q4 2025

Patient Information Guide for Ropivacaine

What It’s Used For

Ropivacaine is an injected local anesthetic for adults, used for numbing during surgery and for acute pain.

  • Surgical anesthesia: epidural block for surgery, including cesarean section
  • Surgical anesthesia: major nerve block
  • Surgical anesthesia: local infiltration
  • Acute pain management: epidural continuous infusion or intermittent bolus, such as after surgery or during labor
  • Acute pain management: local infiltration

Naropin and ropivacaine hydrochloride injection labels list these same uses.

How It Works

Ropivacaine belongs to the amino amide class of local anesthetics. It blocks the start and travel of nerve impulses, apparently by making nerves harder to excite and slowing the signal. Thicker, faster nerve fibers are affected differently than thinner ones, so you lose pain first, then temperature, touch, position sense and muscle tone.

Drug Class

Drug Class

  • Amide Local Anesthetic
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Amide Local Anesthetic

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Ropivacaine in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Local Anesthesia

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Amides

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Amides

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Ropivacaine is given by a clinician, not taken at home. Routes include epidural, around nerves (perineural) and local infiltration.

  • It is given slowly and in small steps, not as one rapid large injection.
  • The lowest effective dose and concentration is used.
  • The amount depends on the procedure, area numbed, tissue blood supply and how long numbness is needed.
  • Food and missed doses do not apply.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Anesthesia for surgery

Adults having surgery with a lumbar epidural · 5 mg Dose 75 to 150 mg
  • 15 to 30 mL (75 to 150 mg)
  • Onset 15 to 30 min
  • Duration 2 to 4 hours
Adults having surgery with a lumbar epidural · 7.5 mg Dose 113 to 188 mg
  • 15 to 25 mL (113 to 188 mg)
  • Onset 10 to 20 min
  • Duration 3 to 5 hours
Adults having surgery with a lumbar epidural · 10 mg Dose 150 to 200 mg
  • 15 to 20 mL (150 to 200 mg)
  • Onset 10 to 20 min
  • Duration 4 to 6 hours
Adults having a cesarean section · 5 mg Dose 100 to 150 mg
  • 20 to 30 mL (100 to 150 mg)
  • Onset 15 to 25 min
  • Duration 2 to 4 hours
Adults having a cesarean section · 7.5 mg Dose 113 to 150 mg
  • 15 to 20 mL (113 to 150 mg)
  • Onset 10 to 20 min
  • Duration 3 to 5 hours
Adults having surgery with a thoracic epidural · 5 mg Dose 25 to 75 mg
  • 5 to 15 mL (25 to 75 mg)
  • Onset 10 to 20 min
  • Duration n/a
Adults having surgery with a thoracic epidural · 7.5 mg Dose 38 to 113 mg
  • 5 to 15 mL (38 to 113 mg)
  • Onset 10 to 20 min
  • Duration n/a
Adults having a major nerve block · 5 mg Dose 175 to 250 mg
  • 35 to 50 mL (175 to 250 mg)
  • Onset 15 to 30 min
  • Duration 5 to 8 hours

Good to know

Dose must be adjusted according to site of administration and patient status

Adults having a major nerve block · 7.5 mg Dose 75 to 300 mg
  • 10 to 40 mL (75 to 300 mg)
  • Onset 10 to 25 min
  • Duration 6 to 10 hours

Good to know

Dose must be adjusted according to site of administration and patient status

Adults having a field block Dose 5 to 200 mg
  • 1 to 40 mL (5 to 200 mg)
  • Onset 1 to 15 min
  • Duration 2 to 6 hours

Pain relief

Women in labor · Initial dose Dose 20 to 40 mg
  • 10 to 20 mL (20 to 40 mg)
  • Onset 10 to15 min
  • Duration 0.5 to 1.5 hours
Women in labor · Continuous infusion Dose 6 to 14 mL/h
  • 6 to 14 mL/h (12 to 28 mg/h)

Good to know

Median dose of 21 mg per hour was given over a median of 5.5 hours

Women in labor · Incremental injections (top-up) Dose 10 to 15 mL/h
  • 10 to 15 mL/h (20 to 30 mg/h)

Good to know

Median dose of 21 mg per hour was given over a median of 5.5 hours

See the Full Dosing Instructions on DailyMed →

Side Effects

Most side effects come from the way regional anesthesia affects the body. Common ones in studies include:

Common side effects

  • Low blood pressure
  • Nausea
  • Vomiting
  • Slow heart rate
  • Fever
  • Headache
  • Itching
  • Back pain

When to get medical help

  • Tell your care team right away about ringing in the ears, numbness or tingling around the mouth, a metallic taste, dizziness, blurred vision, tremors, twitching, restlessness or drowsiness. These can be early signs of nervous system toxicity.
  • Seek urgent help for chest symptoms, a very slow or irregular heartbeat, or trouble breathing. The drug can affect the heart if too much reaches the blood.
  • Report bluish or gray skin color or unusual blood color. These can be signs of methemoglobinemia (a problem with the blood carrying oxygen), which can appear hours later.
  • Report signs of an allergic reaction such as hives, swelling of the face or throat, or fainting.
  • Report joint pain, stiffness or loss of motion after surgery if a local anesthetic was infused into the joint. This can be chondrolysis (cartilage loss).
  • After an epidural, report leg weakness, numbness or loss of bladder or bowel control.

Warnings and Precautions

  • Too much drug in the blood can cause seizures, serious heart rhythm problems and cardiac arrest. Accidental injection into a vein is a key cause.
  • Only trained clinicians with emergency equipment should give it.
  • Methemoglobinemia (blood unable to carry oxygen well) can occur, sometimes hours later.
  • Not approved for joint infusions because of cartilage loss (chondrolysis).
  • Not for spinal, paracervical, retrobulbar or intravenous regional anesthesia.
  • Not recommended when very fast onset is needed.

Interactions

Some medicines can raise ropivacaine's effects or other risks.

  • Other amide-type local anesthetics: toxic effects add up.
  • Fluvoxamine and other strong CYP1A2 inhibitors: slower clearance and higher levels.
  • Ketoconazole: modestly slower clearance.
  • Amiodarone and similar heart rhythm drugs: heart effects may add up.
  • Nitrates, dapsone, sulfonamides, certain antimalarials, anticonvulsants and acetaminophen: higher methemoglobinemia risk.

Interactions Listed in the FDA-Approved Label

From the Ropivacaine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Nitrates/nitrites, other local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants and other drugs associated with methemoglobinemia
    What happensPatients given local anesthetics are at increased risk of methemoglobinemia when exposed to these drugs at the same time.
  • Other local anesthetics or agents structurally related to amide-type local anesthetics
    What happensThe toxic effects of these drugs are additive.
    What to doUse ropivacaine with caution.
  • Strong CYP1A2 inhibitors such as fluvoxamine
    What happensPlasma clearance of ropivacaine was reduced by 70% with fluvoxamine (25 mg bid for 2 days), leading to increased ropivacaine plasma levels.
    What to doCaution should be exercised when CYP1A2 inhibitors are coadministered.
  • Drugs metabolized by CYP1A2 such as theophylline and imipramine
    What happensPossible interactions may occur via competitive inhibition.
  • What happensKetoconazole (100 mg bid for 2 days) caused a 15% reduction in in vivo plasma clearance of ropivacaine.
  • Class III antiarrhythmic drugs For example: amiodarone
    What happensSpecific interaction trials have not been performed.
    What to doCaution is advised.
Read the label’s full interactions text

7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Ropivacaine hydrochloride injection should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive. Cytochrome P4501A2 is involved in the formation of 3-hydroxy ropivacaine, the major metabolite. In vivo, the plasma clearance of ropivacaine was reduced by 70% during coadministration of fluvoxamine (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor. Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of ropivacaine hydrochloride injection, can interact with ropivacaine hydrochloride injection leading to increased ropivacaine plasma levels. Caution should be exercised when CYP1A2 inhibitors are coadministered. Possible interactions with drugs known to be metabolized by CYP1A2 via competitive inhibition such as theophylline and imipramine may also occur.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Allergy to ropivacaine or other amide-type local anesthetics: must not use.
  • Liver disease: higher risk of toxic levels.
  • Kidney problems: higher risk of toxicity.
  • Heart disease, heart block, low blood pressure or low blood volume: extra caution.
  • G6PD deficiency or methemoglobinemia history, and infants under 6 months: higher methemoglobinemia risk.
  • Older or frail patients: lower doses are often needed.
  • Pregnancy: crosses the placenta; no human data on birth defect risk.
  • Breastfeeding: low levels in milk; no infant problems reported.
  • Children: safety and effectiveness not established.

Overdose

Too much ropivacaine, from large doses or accidental injection into a vein or spinal fluid, can cause seizures, breathing problems and serious heart effects. Treatment is to stop the drug at the first sign of toxicity, protect the airway, give oxygen and support breathing and circulation. Treatment is supportive, and seizures are controlled with medicine if needed.

Half-Life and How Your Body Processes It

After epidural injection, ropivacaine is fully absorbed in two phases, a quick one and a slower one that sets how long it lingers. It is about 94% bound to blood proteins and crosses the placenta. The liver breaks it down mainly through CYP1A2, and most is excreted in urine as metabolites, with only about 1% unchanged. The terminal half-life is about 1.8 hours after intravenous dosing and about 4.2 hours after epidural dosing.

Storage

Solutions should be stored at 20ºC to 25°C (68ºF to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ropivacaine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Ropivacaine — the kind of thing our pharmacy team would talk through with you at the counter.

What is ropivacaine used for?

It numbs part of your body for surgery, such as an epidural for cesarean section, a nerve block or numbing around the incision. It also helps control short-term pain, like after surgery or during labor.

How will I get it?

A trained clinician gives it as an injection or infusion, so you won't take it at home. It is given slowly in small steps, and your team picks the dose for your procedure.

What side effects should I expect?

The most common are low blood pressure, nausea, vomiting, a slower heart rate, fever, headache and itching. Your team watches for these and can treat them.

What should I tell my team right away?

Mention ringing in your ears, tingling around the mouth, a metallic taste, dizziness, blurred vision, drowsiness, chest symptoms, trouble breathing, hives or swelling, or bluish skin. These can signal too much drug in the blood, an allergic reaction or methemoglobinemia.

Should I tell you about my other medicines?

Yes. Fluvoxamine can raise ropivacaine levels, and other local anesthetics add to its effects. Amiodarone and drugs linked to methemoglobinemia, like nitrates and sulfonamide antibiotics, also matter.

Is it safe in pregnancy or breastfeeding?

There is no human data on birth defect or miscarriage risk. It crosses the placenta, so mother and baby are monitored during labor. Small amounts reach breast milk, and no problems were reported in infants.

Is ropivacaine available over the counter?

No. Ropivacaine is a prescription medicine: every ropivacaine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was ropivacaine first available?

The earliest FDA record we hold for ropivacaine is from 1996: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when ropivacaine was first used.

Who makes ropivacaine?

19 companies currently list ropivacaine products in the FDA's NDC Directory, including Eugia US LLC, Hikma Pharmaceuticals USA Inc., Meitheal Pharmaceuticals Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of ropivacaine?

Ropivacaine is the generic name. Its brand name is Naropin. Generic versions are listed under the name ropivacaine.

What is the generic name of Naropin?

The generic name of Naropin is ropivacaine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is ropivacaine?

Ropivacaine belongs to the drug class Amide Local Anesthetic, its established pharmacologic class on the FDA label.

Is there a generic version of ropivacaine?

Yes. FDA-approved generic versions of ropivacaine are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does ropivacaine come in?

Ropivacaine is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (around a nerve, into the epidural space, into the tissue at the site): 150 mg/30 mL. Injection (around a nerve, into the epidural space, into the tissue at the site), amount in each mL: 2 mg/mL, 7.5 mg/mL and 10 mg/mL. A listing does not mean every pharmacy stocks every strength.

Is there a ropivacaine shortage?

Yes. Ropivacaine is on the FDA's drug shortage list as of Nov 21, 2026. A shortage means some products are hard to get, not that every pharmacy is out. The shortage page lists the affected products and what each company has told the FDA. Read the ropivacaine shortage page

Where can I read the ropivacaine prescribing information (package insert)?

The full FDA-approved prescribing information for ropivacaine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Fresenius Kabi USA, LLC's, revised Aug 15, 2024, and links to it on DailyMed.

Is ropivacaine gluten free?

No ropivacaine label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 68 ropivacaine products from 18 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's ropivacaine by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See ropivacaine inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Ropivacaine

Skip the scrolling. Ask in your own words and get an answer from Ropivacaine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Ropivacaine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Ropivacaine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Ropivacaine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Ropivacaine Forms and Strengths (How It Comes)

Ropivacaine comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Ropivacaine inactive ingredients by manufacturer.

Injection

Around a nerve · Into the epidural space · Into the tissue at the site
Brands Naropin (the first brand, 1996)
How this form is used
What it may be used for
  • Naropin is used for anesthesia for surgery, including epidural block for cesarean section, major nerve block and local infiltration.
  • Naropin is also used for acute pain management, such as epidural infusion after surgery or in labor, and local infiltration.
  • Ropivacaine hydrochloride injection carries the same surgical anesthesia and acute pain uses.
Important instructions
  • Naropin should be given in small, gradual doses, avoiding rapid injection of a large volume.
  • Naropin is not approved for infusion into joints after surgery.
  • Ropivacaine hydrochloride injection uses the smallest dose and concentration that works, and the dose varies with the procedure.
Available strengths 5 strengths
71 FDA-listed product records ⓘ

Ropivacaine on the U.S. Market: Products, Makers and Brands

How Ropivacaine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

19 companies list 71 Ropivacaine product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1996. The one brand name in the directory today is Naropin; the rest are generics.

1
Dose forms ⓘ
19
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
71
FDA-listed product records ⓘ
1996
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (15) · Unfinished injection, solution (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Eugia US LLC10%
Hikma Pharmaceuticals USA Inc.10%
Meitheal Pharmaceuticals Inc.10%
Somerset Therapeutics, LLC10%
Baxter Healthcare Corporation8%
Caplin Steriles Limited8%
Other makers44%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Ropivacaine Is Used (Medicaid Data)

How many Ropivacaine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

32,308
Medicaid prescriptions filled (Q1–Q4 2025)
$6M paid by Medicaid, before rebates

How commonly is Ropivacaine prescribed? Of the 1,682 medications we measure, Ropivacaine ranks #730 by Medicaid prescriptions — more than 57% of them.

Where Ropivacaine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Ropivacaine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 30 mL / 5 mg/mL injection is the most-dispensed Ropivacaine product — about 56% of these Medicaid prescriptions.

30 ML ropivacaine hydrochloride 5 MG/ML Injection Most dispensed

18,060 Medicaid prescriptions (Q1–Q4 2025) 56% of Ropivacaine prescriptions shown $3.7M paid by Medicaid, before rebates ≈ $207 per prescription, before rebates

12 of 46 listed NDCs had Medicaid claims. RxNorm 1734475

20 ML ropivacaine hydrochloride 5 MG/ML Injection

5,786 Medicaid prescriptions (Q1–Q4 2025) 18% of Ropivacaine prescriptions shown $2M paid by Medicaid, before rebates ≈ $342 per prescription, before rebates

6 of 21 listed NDCs had Medicaid claims. RxNorm 1734483

10 ML ropivacaine hydrochloride 2 MG/ML Injection

4,317 Medicaid prescriptions (Q1–Q4 2025) 13% of Ropivacaine prescriptions shown $77,411 paid by Medicaid, before rebates ≈ $18 per prescription, before rebates

4 of 12 listed NDCs had Medicaid claims. RxNorm 1734203

20 ML ropivacaine hydrochloride 2 MG/ML Injection

2,771 Medicaid prescriptions (Q1–Q4 2025) 9% of Ropivacaine prescriptions shown $198,778 paid by Medicaid, before rebates ≈ $72 per prescription, before rebates

8 of 28 listed NDCs had Medicaid claims. RxNorm 1734207

100 ML ropivacaine hydrochloride 2 MG/ML Injection

678 Medicaid prescriptions (Q1–Q4 2025) 2% of Ropivacaine prescriptions shown $2,771 paid by Medicaid, before rebates ≈ $4.09 per prescription, before rebates

3 of 27 listed NDCs had Medicaid claims. RxNorm 1734347

200 ML ropivacaine hydrochloride 2 MG/ML Injection

320 Medicaid prescriptions (Q1–Q4 2025) <1% of Ropivacaine prescriptions shown $215 paid by Medicaid, before rebates ≈ $0.67 per prescription, before rebates

4 of 24 listed NDCs had Medicaid claims. RxNorm 1734355

10 ML ropivacaine hydrochloride 10 MG/ML Injection

182 Medicaid prescriptions (Q1–Q4 2025) <1% of Ropivacaine prescriptions shown $10,812 paid by Medicaid, before rebates ≈ $59 per prescription, before rebates

3 of 11 listed NDCs had Medicaid claims. RxNorm 1734090

20 ML ropivacaine hydrochloride 10 MG/ML Injection

80 Medicaid prescriptions (Q1–Q4 2025) <1% of Ropivacaine prescriptions shown $13,164 paid by Medicaid, before rebates ≈ $165 per prescription, before rebates

3 of 30 listed NDCs had Medicaid claims. RxNorm 1734084

20 ML ropivacaine hydrochloride 7.5 MG/ML Injection

61 Medicaid prescriptions (Q1–Q4 2025) <1% of Ropivacaine prescriptions shown $7,629 paid by Medicaid, before rebates ≈ $125 per prescription, before rebates

1 of 12 listed NDCs had Medicaid claims. RxNorm 905189

200 ML ropivacaine hydrochloride 5 MG/ML Injection

42 Medicaid prescriptions (Q1–Q4 2025) <1% of Ropivacaine prescriptions shown $1,117 paid by Medicaid, before rebates ≈ $27 per prescription, before rebates

2 of 5 listed NDCs had Medicaid claims. RxNorm 1734481

100 ML ropivacaine hydrochloride 5 MG/ML Injection

11 Medicaid prescriptions (Q1–Q4 2025) <1% of Ropivacaine prescriptions shown

1 of 8 listed NDCs had Medicaid claims. RxNorm 1734479

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 47 of the 224 listed Ropivacaine NDCs had Medicaid claims.

Compare Ropivacaine Products

A representative set of FDA-listed product records for Ropivacaine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 71 of 71 products — FDA National Drug Code Directory. See every product, package size and price: browse all 71 Ropivacaine NDCs →

Ropivacaine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 2 Ropivacaine recalls since July 2021. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Jul 16, 2026 · Fresenius Kabi USA, LLC
Presence of Particulate Matter: Hair was found in products
  • Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23;… Lots: Lot #: 6133436, Exp. Date 10/2028 FDA record D-0727-2026 →
Class I Apr 17, 2025 · Terminated · Amneal Pharmaceuticals, LLC
Presence of Particulate Matter
  • Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewate… Lots: Lot #'s: AL240003, AL240004, Exp.: 01/31/2026 FDA record D-0402-2025 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Ropivacaine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
13
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Ropivacaine RxCUI 35780
  1. Dose form (SCDF) Prefilled Syringe RxCUI 1996290
    In current FDA listings
    Its 2 strengths (SCD)
    • 10 mL ropivacaine hydrochloride 2 mg/mL RxCUI 1996297
    • 10 mL ropivacaine hydrochloride 5 mg/mL RxCUI 1996291

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Ropivacaine Brand Names

Ropivacaine has one brand name on record: Naropin. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Naropin the first brand, 1996

Who Makes Ropivacaine: Manufacturers and Labelers

19 companies list Ropivacaine products with the FDA. By number of product records, the largest are Eugia US LLC, Hikma Pharmaceuticals USA Inc., Meitheal Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Eugia US LLC 7 Hikma Pharmaceuticals USA Inc. 7 Meitheal Pharmaceuticals Inc. 7 Somerset Therapeutics, LLC 7 Baxter Healthcare Corporation 6 Caplin Steriles Limited 6 Fresenius Kabi USA, LLC 5 Glenmark Pharmaceuticals Inc., USA 5 Amneal Pharmaceuticals LLC 4 Anthea Pharma Private Limited 3 Gland Pharma Limited 2 Mylan Institutional LLC 2 SOLA Pharmaceuticals, LLC 2 Sagent Pharmaceuticals 2 Sportpharm LLC 2 Armas Pharmaceuticals Inc. 1 Civica, Inc. 1 Henry Schein, Inc. 1 ProPharma Distribution 1

Sources for This Ropivacaine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Aug 15, 2024, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Ropivacaine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 30 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
30
Finished products in the current FDA directory
71
Companies listing them (makers, repackagers, distributors)
19
FDA labeler codes behind them ⓘ
20
Linked representative label ⓘ
Fresenius Kabi USA, LLC
Linked label effective
Aug 15, 2024
Composite sections available
23
Linked SPL Set ID
dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7
Linked SPL Document ID
324532ac-4e54-4659-a1a2-9ade22a1ed3f
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 23
63323-0285-10 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-13 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-20 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-23 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-28 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-61 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-63 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-64 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-65 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-67 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-68 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0285-73 Naropin ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-00 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-20 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-23 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-27 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-30 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-31 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-35 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius 63323-0286-38 Naropin ropivacaine hydrochloride 5 mg/mL INJECTION, SOLUTION Fresenius

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →